home / stock / xair / xair news


XAIR News and Press, Beyond Air Inc. From 12/09/21

Stock Information

Company Name: Beyond Air Inc.
Stock Symbol: XAIR
Market: NASDAQ
Website: beyondair.net

Menu

XAIR XAIR Quote XAIR Short XAIR News XAIR Articles XAIR Message Board
Get XAIR Alerts

News, Short Squeeze, Breakout and More Instantly...

XAIR - CCNC, BJDX and ISIG among mid-day movers

Gainers: Inspira Technologies (NASDAQ:IINN) +92%. Ensysce Biosciences (NASDAQ:ENSC) +79%. Insignia (NASDAQ:ISIG) +44%. Hovnanian Enterprises (NASDAQ:HOVNP) +33%. American Virtual Cloud Technologies (NASDAQ:AVCT) +31%. Blue Star Foods Corp. (NASDAQ:BSFC) +16%. Hovnanian (NYSE:HO...

XAIR - Why Beyond Air Stock Is Tanking Today

Shares of the clinical-stage medical device and biopharmaceutical company Beyond Air (NASDAQ: XAIR) are down by a hefty 24.9% as of 11:13 a.m. ET Thursday morning. The healthcare company's stock is crashing today in response to a regulatory delay for its persistent pulmonary hyp...

XAIR - Inspira Technologies, Ensysce Biosciences leads healthcare gainers; Reata Pharmaceuticals, Beyond Air among major losers

Gainers: Inspira Technologies (NASDAQ:IINN) +103%, Ensysce Biosciences (NASDAQ:ENSC) +53%, Jasper Therapeutics (NASDAQ:JSPR) +24%, Ambrx Biopharma (NYSE:AMAM) +17%, iSpecimen (NASDAQ:ISPC) +15%. Losers: Reata Pharmaceuticals (NASDAQ:RETA)...

XAIR - Beyond Air says U.S. launch of LungFit system unlikely before year-end

Beyond Air (XAIR -22.9%) shares have approached the lowest level since mid-August after the company cited its ongoing discussions with the FDA to indicate that its U.S. commercial launch of LungFit PH is unlikely to happen before Dec. 31, 2021. However, Beyond Air (NASDAQ:XAIR) reiterated its...

XAIR - Beyond Air® Provides Regulatory Update for LungFit® PH

GARDEN CITY, N.Y., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections an...

XAIR - XAIR, NTP and RAAS among mid-day movers

Gainers: Del Taco Restaurants (NASDAQ:TACO) +66%. Insignia Systems (NASDAQ:ISIG) +64%. Adicet Bio (NASDAQ:ACET) +37%. Cloopen Group (NYSE:RAAS) +24%. eFFECTOR Therapeutics (NASDAQ:EFTR) +20%. Recruiter (NASDAQ:RCRT) +21%. Edgewise Therapeutics (NASDAQ:EWTX) +21%. Liberty TripAdvisor (NASDAQ:L...

XAIR - Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer

Dr. Colin brings four decades of clinical experience in pediatric pulmonology to Beyond Air, with research spanning respiratory physiology, Cystic Fibrosis, and lung infections culminating in over 120 peer-reviewed publications and 250 global lectures As a board-certified pediat...

XAIR - 3 Small-Cap COVID Stocks With Huge Upside

While large-cap stocks are usually safer, small-cap stocks are often way more exciting. If you own the right small cap, you can make a lot of money as your company becomes the large cap of tomorrow. This panel of Fool.com contributors has three small-cap COVID-19 stock ideas for intrepi...

XAIR - Beyond Air gets $30 million worth of commitments for cancer division

Beyond Air (NASDAQ:XAIR) announced a $30M worth of commitments secured for its private affiliate, Beyond Cancer, through private placement of common shares. The investors who have made the financial commitment could receive 20% equity ownership, the company disclosed. The transaction is expec...

XAIR - Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer(TM) Private Placement

GARDEN CITY, N.Y., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections an...

Previous 10 Next 10